nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP3A4—Everolimus—kidney cancer	0.0973	0.135	CbGbCtD
Sulfadiazine—CYP2C8—Pazopanib—kidney cancer	0.0851	0.118	CbGbCtD
Sulfadiazine—CYP3A4—Temsirolimus—kidney cancer	0.0657	0.0915	CbGbCtD
Sulfadiazine—CYP2C9—Capecitabine—kidney cancer	0.0619	0.0862	CbGbCtD
Sulfadiazine—CYP2C8—Erlotinib—kidney cancer	0.0607	0.0845	CbGbCtD
Sulfadiazine—CYP2C8—Paclitaxel—kidney cancer	0.0556	0.0774	CbGbCtD
Sulfadiazine—CYP2C8—Sorafenib—kidney cancer	0.0494	0.0687	CbGbCtD
Sulfadiazine—CYP2C9—Paclitaxel—kidney cancer	0.0388	0.054	CbGbCtD
Sulfadiazine—CYP3A4—Pazopanib—kidney cancer	0.0345	0.0481	CbGbCtD
Sulfadiazine—CYP2C9—Sorafenib—kidney cancer	0.0344	0.0479	CbGbCtD
Sulfadiazine—CYP3A4—Erlotinib—kidney cancer	0.0246	0.0343	CbGbCtD
Sulfadiazine—CYP3A4—Paclitaxel—kidney cancer	0.0226	0.0314	CbGbCtD
Sulfadiazine—CYP3A4—Sorafenib—kidney cancer	0.02	0.0279	CbGbCtD
Sulfadiazine—CYP3A4—Vinblastine—kidney cancer	0.0198	0.0275	CbGbCtD
Sulfadiazine—CYP3A4—Vincristine—kidney cancer	0.0194	0.0271	CbGbCtD
Sulfadiazine—CYP3A4—Sunitinib—kidney cancer	0.0162	0.0226	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—kidney cancer	0.0122	0.0169	CbGbCtD
Sulfadiazine—Sulfanilamide—CA9—kidney cancer	0.000982	0.237	CrCbGaD
Sulfadiazine—Sulfanilamide—CA2—kidney cancer	0.000883	0.213	CrCbGaD
Sulfadiazine—Sulfasalazine—PTGS1—kidney cancer	0.000667	0.161	CrCbGaD
Sulfadiazine—CYP2C9—urine—kidney cancer	0.000645	0.22	CbGeAlD
Sulfadiazine—CYP2E1—urine—kidney cancer	0.000611	0.208	CbGeAlD
Sulfadiazine—Pruritus—Temsirolimus—kidney cancer	0.000566	0.00216	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Erlotinib—kidney cancer	0.000562	0.00215	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—PTGS1—kidney cancer	0.000553	0.133	CrCbGaD
Sulfadiazine—Skin discolouration—Doxorubicin—kidney cancer	0.000548	0.0021	CcSEcCtD
Sulfadiazine—Diarrhoea—Temsirolimus—kidney cancer	0.000547	0.00209	CcSEcCtD
Sulfadiazine—Anorexia—Erlotinib—kidney cancer	0.000547	0.00209	CcSEcCtD
Sulfadiazine—Leukopenia—Sunitinib—kidney cancer	0.000545	0.00209	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000542	0.00207	CcSEcCtD
Sulfadiazine—Arthralgia—Sorafenib—kidney cancer	0.000539	0.00206	CcSEcCtD
Sulfadiazine—Insomnia—Everolimus—kidney cancer	0.000538	0.00206	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—kidney cancer	0.000537	0.00205	CcSEcCtD
Sulfadiazine—Pruritus—Pazopanib—kidney cancer	0.000533	0.00204	CcSEcCtD
Sulfadiazine—Erythema multiforme—Gemcitabine—kidney cancer	0.000531	0.00203	CcSEcCtD
Sulfadiazine—Convulsion—Sunitinib—kidney cancer	0.000527	0.00202	CcSEcCtD
Sulfadiazine—Ataxia—Capecitabine—kidney cancer	0.000524	0.00201	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000523	0.002	CcSEcCtD
Sulfadiazine—Depression—Paclitaxel—kidney cancer	0.000522	0.002	CcSEcCtD
Sulfadiazine—Insomnia—Erlotinib—kidney cancer	0.000519	0.00199	CcSEcCtD
Sulfadiazine—Decreased appetite—Vinblastine—kidney cancer	0.000519	0.00199	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000519	0.00199	CcSEcCtD
Sulfadiazine—Arthralgia—Sunitinib—kidney cancer	0.000518	0.00198	CcSEcCtD
Sulfadiazine—Decreased appetite—Everolimus—kidney cancer	0.000517	0.00198	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Sorafenib—kidney cancer	0.000516	0.00198	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—kidney cancer	0.000516	0.00197	CcSEcCtD
Sulfadiazine—Diarrhoea—Pazopanib—kidney cancer	0.000515	0.00197	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Everolimus—kidney cancer	0.000514	0.00196	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000513	0.00196	CcSEcCtD
Sulfadiazine—Stomatitis—Paclitaxel—kidney cancer	0.00051	0.00195	CcSEcCtD
Sulfadiazine—Vomiting—Temsirolimus—kidney cancer	0.000508	0.00195	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Sorafenib—kidney cancer	0.000506	0.00193	CcSEcCtD
Sulfadiazine—Rash—Temsirolimus—kidney cancer	0.000504	0.00193	CcSEcCtD
Sulfadiazine—Dermatitis—Temsirolimus—kidney cancer	0.000504	0.00193	CcSEcCtD
Sulfadiazine—Chills—Gemcitabine—kidney cancer	0.000503	0.00193	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000502	0.00192	CcSEcCtD
Sulfadiazine—Headache—Temsirolimus—kidney cancer	0.000501	0.00192	CcSEcCtD
Sulfadiazine—Decreased appetite—Erlotinib—kidney cancer	0.000499	0.00191	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000495	0.0019	CcSEcCtD
Sulfadiazine—Anorexia—Sorafenib—kidney cancer	0.000492	0.00188	CcSEcCtD
Sulfadiazine—CYP3A4—urine—kidney cancer	0.000492	0.168	CbGeAlD
Sulfadiazine—Gastrointestinal pain—Vinblastine—kidney cancer	0.000488	0.00187	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Sunitinib—kidney cancer	0.000486	0.00186	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Everolimus—kidney cancer	0.000486	0.00186	CcSEcCtD
Sulfadiazine—Vomiting—Pazopanib—kidney cancer	0.000479	0.00183	CcSEcCtD
Sulfadiazine—Rash—Pazopanib—kidney cancer	0.000475	0.00182	CcSEcCtD
Sulfadiazine—Nausea—Temsirolimus—kidney cancer	0.000475	0.00182	CcSEcCtD
Sulfadiazine—Dermatitis—Pazopanib—kidney cancer	0.000475	0.00182	CcSEcCtD
Sulfadiazine—Anorexia—Sunitinib—kidney cancer	0.000474	0.00181	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—kidney cancer	0.000472	0.00181	CcSEcCtD
Sulfadiazine—Abdominal pain—Vinblastine—kidney cancer	0.000472	0.00181	CcSEcCtD
Sulfadiazine—Headache—Pazopanib—kidney cancer	0.000472	0.00181	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00047	0.0018	CcSEcCtD
Sulfadiazine—Abdominal pain—Everolimus—kidney cancer	0.00047	0.0018	CcSEcCtD
Sulfadiazine—Body temperature increased—Everolimus—kidney cancer	0.00047	0.0018	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000469	0.0018	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—kidney cancer	0.000465	0.00178	CcSEcCtD
Sulfadiazine—Vertigo—Vincristine—kidney cancer	0.000463	0.00177	CcSEcCtD
Sulfadiazine—Leukopenia—Vincristine—kidney cancer	0.000461	0.00176	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000461	0.00176	CcSEcCtD
Sulfadiazine—Abdominal pain—Erlotinib—kidney cancer	0.000454	0.00174	CcSEcCtD
Sulfadiazine—Body temperature increased—Erlotinib—kidney cancer	0.000454	0.00174	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000453	0.00173	CcSEcCtD
Sulfadiazine—Insomnia—Sunitinib—kidney cancer	0.000449	0.00172	CcSEcCtD
Sulfadiazine—Decreased appetite—Sorafenib—kidney cancer	0.000449	0.00172	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—kidney cancer	0.000448	0.00172	CcSEcCtD
Sulfadiazine—Nausea—Pazopanib—kidney cancer	0.000447	0.00171	CcSEcCtD
Sulfadiazine—Convulsion—Vincristine—kidney cancer	0.000446	0.00171	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000446	0.00171	CcSEcCtD
Sulfadiazine—Erythema multiforme—Paclitaxel—kidney cancer	0.000444	0.0017	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vinblastine—kidney cancer	0.00044	0.00168	CcSEcCtD
Sulfadiazine—Hypersensitivity—Everolimus—kidney cancer	0.000438	0.00168	CcSEcCtD
Sulfadiazine—Tinnitus—Paclitaxel—kidney cancer	0.000438	0.00168	CcSEcCtD
Sulfadiazine—Leukopenia—Gemcitabine—kidney cancer	0.000437	0.00167	CcSEcCtD
Sulfadiazine—Dapsone—PTGS1—kidney cancer	0.000433	0.104	CrCbGaD
Sulfadiazine—Decreased appetite—Sunitinib—kidney cancer	0.000432	0.00165	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—kidney cancer	0.000429	0.00164	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000429	0.00164	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000429	0.00164	CcSEcCtD
Sulfadiazine—Depression—Capecitabine—kidney cancer	0.000428	0.00164	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000426	0.00163	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000422	0.00162	CcSEcCtD
Sulfadiazine—Chills—Paclitaxel—kidney cancer	0.000422	0.00161	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Capecitabine—kidney cancer	0.000421	0.00161	CcSEcCtD
Sulfadiazine—Pruritus—Everolimus—kidney cancer	0.000421	0.00161	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Vincristine—kidney cancer	0.00042	0.00161	CcSEcCtD
Sulfadiazine—Stomatitis—Capecitabine—kidney cancer	0.000419	0.0016	CcSEcCtD
Sulfadiazine—Arthralgia—Gemcitabine—kidney cancer	0.000416	0.00159	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Vincristine—kidney cancer	0.000411	0.00157	CcSEcCtD
Sulfadiazine—Urticaria—Sorafenib—kidney cancer	0.00041	0.00157	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—kidney cancer	0.000409	0.00156	CcSEcCtD
Sulfadiazine—Diarrhoea—Vinblastine—kidney cancer	0.000409	0.00156	CcSEcCtD
Sulfadiazine—Body temperature increased—Sorafenib—kidney cancer	0.000408	0.00156	CcSEcCtD
Sulfadiazine—Abdominal pain—Sorafenib—kidney cancer	0.000408	0.00156	CcSEcCtD
Sulfadiazine—Diarrhoea—Everolimus—kidney cancer	0.000407	0.00156	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000406	0.00155	CcSEcCtD
Sulfadiazine—Pruritus—Erlotinib—kidney cancer	0.000406	0.00155	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—kidney cancer	0.000402	0.00154	CcSEcCtD
Sulfadiazine—Agranulocytosis—Capecitabine—kidney cancer	0.000401	0.00153	CcSEcCtD
Sulfadiazine—Anorexia—Vincristine—kidney cancer	0.000401	0.00153	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000399	0.00153	CcSEcCtD
Sulfadiazine—Abdominal pain—Sunitinib—kidney cancer	0.000393	0.0015	CcSEcCtD
Sulfadiazine—Body temperature increased—Sunitinib—kidney cancer	0.000393	0.0015	CcSEcCtD
Sulfadiazine—Diarrhoea—Erlotinib—kidney cancer	0.000393	0.0015	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Gemcitabine—kidney cancer	0.00039	0.00149	CcSEcCtD
Sulfadiazine—Hepatitis—Capecitabine—kidney cancer	0.000386	0.00148	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000385	0.00147	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000383	0.00147	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—kidney cancer	0.000381	0.092	CrCbGaD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000381	0.00146	CcSEcCtD
Sulfadiazine—Hypersensitivity—Sorafenib—kidney cancer	0.00038	0.00146	CcSEcCtD
Sulfadiazine—Insomnia—Vincristine—kidney cancer	0.00038	0.00145	CcSEcCtD
Sulfadiazine—Anorexia—Gemcitabine—kidney cancer	0.00038	0.00145	CcSEcCtD
Sulfadiazine—Vomiting—Vinblastine—kidney cancer	0.00038	0.00145	CcSEcCtD
Sulfadiazine—Vomiting—Everolimus—kidney cancer	0.000378	0.00145	CcSEcCtD
Sulfadiazine—Rash—Everolimus—kidney cancer	0.000375	0.00144	CcSEcCtD
Sulfadiazine—Dermatitis—Everolimus—kidney cancer	0.000375	0.00143	CcSEcCtD
Sulfadiazine—Headache—Vinblastine—kidney cancer	0.000374	0.00143	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—kidney cancer	0.000373	0.00143	CcSEcCtD
Sulfadiazine—Headache—Everolimus—kidney cancer	0.000373	0.00143	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—kidney cancer	0.000372	0.00142	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—kidney cancer	0.000372	0.00142	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000371	0.00142	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000368	0.00141	CcSEcCtD
Sulfadiazine—Vertigo—Paclitaxel—kidney cancer	0.000367	0.00141	CcSEcCtD
Sulfadiazine—Leukopenia—Paclitaxel—kidney cancer	0.000366	0.0014	CcSEcCtD
Sulfadiazine—Hypersensitivity—Sunitinib—kidney cancer	0.000366	0.0014	CcSEcCtD
Sulfadiazine—Decreased appetite—Vincristine—kidney cancer	0.000365	0.0014	CcSEcCtD
Sulfadiazine—Pruritus—Sorafenib—kidney cancer	0.000365	0.0014	CcSEcCtD
Sulfadiazine—Vomiting—Erlotinib—kidney cancer	0.000365	0.0014	CcSEcCtD
Sulfadiazine—Erythema multiforme—Capecitabine—kidney cancer	0.000365	0.00139	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000363	0.00139	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000363	0.00139	CcSEcCtD
Sulfadiazine—Rash—Erlotinib—kidney cancer	0.000362	0.00138	CcSEcCtD
Sulfadiazine—Dermatitis—Erlotinib—kidney cancer	0.000362	0.00138	CcSEcCtD
Sulfadiazine—Insomnia—Gemcitabine—kidney cancer	0.000361	0.00138	CcSEcCtD
Sulfadiazine—Headache—Erlotinib—kidney cancer	0.00036	0.00138	CcSEcCtD
Sulfadiazine—Tinnitus—Capecitabine—kidney cancer	0.000359	0.00138	CcSEcCtD
Sulfadiazine—Nausea—Vinblastine—kidney cancer	0.000355	0.00136	CcSEcCtD
Sulfadiazine—Convulsion—Paclitaxel—kidney cancer	0.000354	0.00136	CcSEcCtD
Sulfadiazine—Nausea—Everolimus—kidney cancer	0.000353	0.00135	CcSEcCtD
Sulfadiazine—Diarrhoea—Sorafenib—kidney cancer	0.000353	0.00135	CcSEcCtD
Sulfadiazine—Pruritus—Sunitinib—kidney cancer	0.000351	0.00135	CcSEcCtD
Sulfadiazine—Arthralgia—Paclitaxel—kidney cancer	0.000348	0.00133	CcSEcCtD
Sulfadiazine—Decreased appetite—Gemcitabine—kidney cancer	0.000347	0.00133	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—kidney cancer	0.000347	0.00133	CcSEcCtD
Sulfadiazine—Chills—Capecitabine—kidney cancer	0.000346	0.00132	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000344	0.00132	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vincristine—kidney cancer	0.000344	0.00131	CcSEcCtD
Sulfadiazine—Nausea—Erlotinib—kidney cancer	0.000341	0.0013	CcSEcCtD
Sulfadiazine—Diarrhoea—Sunitinib—kidney cancer	0.00034	0.0013	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—kidney cancer	0.000338	0.00129	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000334	0.00128	CcSEcCtD
Sulfadiazine—Abdominal pain—Vincristine—kidney cancer	0.000332	0.00127	CcSEcCtD
Sulfadiazine—Body temperature increased—Vincristine—kidney cancer	0.000332	0.00127	CcSEcCtD
Sulfadiazine—Vomiting—Sorafenib—kidney cancer	0.000328	0.00126	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000327	0.00125	CcSEcCtD
Sulfadiazine—Rash—Sorafenib—kidney cancer	0.000326	0.00125	CcSEcCtD
Sulfadiazine—Dermatitis—Sorafenib—kidney cancer	0.000325	0.00124	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000323	0.00124	CcSEcCtD
Sulfadiazine—Headache—Sorafenib—kidney cancer	0.000323	0.00124	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—kidney cancer	0.000322	0.00123	CcSEcCtD
Sulfadiazine—Anorexia—Paclitaxel—kidney cancer	0.000318	0.00122	CcSEcCtD
Sulfadiazine—Vomiting—Sunitinib—kidney cancer	0.000316	0.00121	CcSEcCtD
Sulfadiazine—Body temperature increased—Gemcitabine—kidney cancer	0.000315	0.00121	CcSEcCtD
Sulfadiazine—Rash—Sunitinib—kidney cancer	0.000313	0.0012	CcSEcCtD
Sulfadiazine—Dermatitis—Sunitinib—kidney cancer	0.000313	0.0012	CcSEcCtD
Sulfadiazine—Headache—Sunitinib—kidney cancer	0.000311	0.00119	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vincristine—kidney cancer	0.00031	0.00118	CcSEcCtD
Sulfadiazine—Nausea—Sorafenib—kidney cancer	0.000307	0.00117	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—kidney cancer	0.000304	0.00116	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000304	0.00116	CcSEcCtD
Sulfadiazine—Insomnia—Paclitaxel—kidney cancer	0.000302	0.00116	CcSEcCtD
Sulfadiazine—Vertigo—Capecitabine—kidney cancer	0.000302	0.00115	CcSEcCtD
Sulfadiazine—Leukopenia—Capecitabine—kidney cancer	0.0003	0.00115	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—kidney cancer	0.000299	0.00114	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—kidney cancer	0.000297	0.00113	CcSEcCtD
Sulfadiazine—Nausea—Sunitinib—kidney cancer	0.000295	0.00113	CcSEcCtD
Sulfadiazine—Decreased appetite—Paclitaxel—kidney cancer	0.00029	0.00111	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000288	0.0011	CcSEcCtD
Sulfadiazine—Diarrhoea—Vincristine—kidney cancer	0.000288	0.0011	CcSEcCtD
Sulfadiazine—Arthralgia—Capecitabine—kidney cancer	0.000286	0.00109	CcSEcCtD
Sulfadiazine—Pruritus—Gemcitabine—kidney cancer	0.000282	0.00108	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—kidney cancer	0.000279	0.00107	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000274	0.00105	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000273	0.00104	CcSEcCtD
Sulfadiazine—Diarrhoea—Gemcitabine—kidney cancer	0.000273	0.00104	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000271	0.00104	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—kidney cancer	0.00027	0.00103	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Capecitabine—kidney cancer	0.000268	0.00103	CcSEcCtD
Sulfadiazine—Vomiting—Vincristine—kidney cancer	0.000267	0.00102	CcSEcCtD
Sulfadiazine—Urticaria—Paclitaxel—kidney cancer	0.000265	0.00101	CcSEcCtD
Sulfadiazine—Rash—Vincristine—kidney cancer	0.000265	0.00101	CcSEcCtD
Sulfadiazine—Dermatitis—Vincristine—kidney cancer	0.000265	0.00101	CcSEcCtD
Sulfadiazine—Abdominal pain—Paclitaxel—kidney cancer	0.000264	0.00101	CcSEcCtD
Sulfadiazine—Body temperature increased—Paclitaxel—kidney cancer	0.000264	0.00101	CcSEcCtD
Sulfadiazine—Headache—Vincristine—kidney cancer	0.000263	0.00101	CcSEcCtD
Sulfadiazine—Anorexia—Capecitabine—kidney cancer	0.000261	0.000999	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000258	0.000989	CcSEcCtD
Sulfadiazine—Vomiting—Gemcitabine—kidney cancer	0.000253	0.00097	CcSEcCtD
Sulfadiazine—Rash—Gemcitabine—kidney cancer	0.000251	0.000962	CcSEcCtD
Sulfadiazine—Dermatitis—Gemcitabine—kidney cancer	0.000251	0.000961	CcSEcCtD
Sulfadiazine—Headache—Gemcitabine—kidney cancer	0.00025	0.000956	CcSEcCtD
Sulfadiazine—Nausea—Vincristine—kidney cancer	0.00025	0.000955	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00025	0.000955	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—kidney cancer	0.000249	0.000951	CcSEcCtD
Sulfadiazine—Insomnia—Capecitabine—kidney cancer	0.000248	0.000948	CcSEcCtD
Sulfadiazine—Dapsone—PTGS2—kidney cancer	0.000247	0.0596	CrCbGaD
Sulfadiazine—Hypersensitivity—Paclitaxel—kidney cancer	0.000246	0.000941	CcSEcCtD
Sulfadiazine—Decreased appetite—Capecitabine—kidney cancer	0.000238	0.000911	CcSEcCtD
Sulfadiazine—Nausea—Gemcitabine—kidney cancer	0.000237	0.000906	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000236	0.000905	CcSEcCtD
Sulfadiazine—Pruritus—Paclitaxel—kidney cancer	0.000236	0.000904	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—kidney cancer	0.000235	0.000899	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—kidney cancer	0.000232	0.000887	CcSEcCtD
Sulfadiazine—Diarrhoea—Paclitaxel—kidney cancer	0.000228	0.000874	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000224	0.000857	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—kidney cancer	0.000223	0.000853	CcSEcCtD
Sulfadiazine—Urticaria—Capecitabine—kidney cancer	0.000218	0.000833	CcSEcCtD
Sulfadiazine—Body temperature increased—Capecitabine—kidney cancer	0.000217	0.000829	CcSEcCtD
Sulfadiazine—Abdominal pain—Capecitabine—kidney cancer	0.000217	0.000829	CcSEcCtD
Sulfadiazine—Vomiting—Paclitaxel—kidney cancer	0.000212	0.000812	CcSEcCtD
Sulfadiazine—Rash—Paclitaxel—kidney cancer	0.00021	0.000805	CcSEcCtD
Sulfadiazine—Dermatitis—Paclitaxel—kidney cancer	0.00021	0.000805	CcSEcCtD
Sulfadiazine—Headache—Paclitaxel—kidney cancer	0.000209	0.0008	CcSEcCtD
Sulfadiazine—Hypersensitivity—Capecitabine—kidney cancer	0.000202	0.000772	CcSEcCtD
Sulfadiazine—Nausea—Paclitaxel—kidney cancer	0.000198	0.000759	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—kidney cancer	0.000194	0.000744	CcSEcCtD
Sulfadiazine—Pruritus—Capecitabine—kidney cancer	0.000194	0.000742	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—kidney cancer	0.000194	0.000741	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—kidney cancer	0.000187	0.000717	CcSEcCtD
Sulfadiazine—Diarrhoea—Capecitabine—kidney cancer	0.000187	0.000717	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—kidney cancer	0.000184	0.000705	CcSEcCtD
Sulfadiazine—CYP2C8—renal system—kidney cancer	0.000178	0.0605	CbGeAlD
Sulfadiazine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000177	0.000676	CcSEcCtD
Sulfadiazine—Vomiting—Capecitabine—kidney cancer	0.000174	0.000666	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000173	0.000661	CcSEcCtD
Sulfadiazine—Rash—Capecitabine—kidney cancer	0.000173	0.000661	CcSEcCtD
Sulfadiazine—Dermatitis—Capecitabine—kidney cancer	0.000173	0.00066	CcSEcCtD
Sulfadiazine—CYP2C8—kidney—kidney cancer	0.000172	0.0585	CbGeAlD
Sulfadiazine—Headache—Capecitabine—kidney cancer	0.000172	0.000657	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—kidney cancer	0.000168	0.000644	CcSEcCtD
Sulfadiazine—CYP2E1—nephron tubule—kidney cancer	0.000165	0.0561	CbGeAlD
Sulfadiazine—Nausea—Capecitabine—kidney cancer	0.000163	0.000623	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000161	0.000616	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—kidney cancer	0.00016	0.000611	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—kidney cancer	0.000153	0.000587	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000152	0.000583	CcSEcCtD
Sulfadiazine—CYP2E1—renal system—kidney cancer	0.00015	0.051	CbGeAlD
Sulfadiazine—CYP2E1—kidney—kidney cancer	0.000145	0.0493	CbGeAlD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000144	0.000552	CcSEcCtD
Sulfadiazine—CYP2E1—cortex of kidney—kidney cancer	0.000141	0.048	CbGeAlD
Sulfadiazine—Urticaria—Doxorubicin—kidney cancer	0.00014	0.000537	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—kidney cancer	0.00014	0.000534	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—kidney cancer	0.00014	0.000534	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—kidney cancer	0.00013	0.000498	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—kidney cancer	0.000125	0.000478	CcSEcCtD
Sulfadiazine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000123	0.00931	CbGpPWpGaD
Sulfadiazine—CYP2C9—Xenobiotics—CYP1A1—kidney cancer	0.000121	0.00921	CbGpPWpGaD
Sulfadiazine—Diarrhoea—Doxorubicin—kidney cancer	0.000121	0.000462	CcSEcCtD
Sulfadiazine—CYP3A4—renal system—kidney cancer	0.00012	0.041	CbGeAlD
Sulfadiazine—CYP2C9—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000117	0.00886	CbGpPWpGaD
Sulfadiazine—CYP3A4—kidney—kidney cancer	0.000116	0.0396	CbGeAlD
Sulfadiazine—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000116	0.00879	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000115	0.00874	CbGpPWpGaD
Sulfadiazine—Vomiting—Doxorubicin—kidney cancer	0.000112	0.00043	CcSEcCtD
Sulfadiazine—CYP2C9—Biological oxidations—ACY1—kidney cancer	0.000112	0.00847	CbGpPWpGaD
Sulfadiazine—Rash—Doxorubicin—kidney cancer	0.000111	0.000426	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—kidney cancer	0.000111	0.000426	CcSEcCtD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000111	0.00844	CbGpPWpGaD
Sulfadiazine—Headache—Doxorubicin—kidney cancer	0.000111	0.000423	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—kidney cancer	0.000105	0.000401	CcSEcCtD
Sulfadiazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	9.9e-05	0.00752	CbGpPWpGaD
Sulfadiazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	9.56e-05	0.00726	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	9.18e-05	0.00697	CbGpPWpGaD
Sulfadiazine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	9.05e-05	0.00687	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS1—kidney cancer	9.04e-05	0.00687	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	9.01e-05	0.00684	CbGpPWpGaD
Sulfadiazine—CYP2E1—Tryptophan metabolism—CYP1A1—kidney cancer	8.85e-05	0.00673	CbGpPWpGaD
Sulfadiazine—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	8.7e-05	0.00661	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—ALDH1A1—kidney cancer	8.69e-05	0.0066	CbGpPWpGaD
Sulfadiazine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	8.62e-05	0.00655	CbGpPWpGaD
Sulfadiazine—CYP3A4—Irinotecan Pathway—APC—kidney cancer	8.33e-05	0.00633	CbGpPWpGaD
Sulfadiazine—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	8e-05	0.00608	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	7.78e-05	0.00591	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	7.69e-05	0.00584	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	7.59e-05	0.00576	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—ALDH1A1—kidney cancer	7.51e-05	0.0057	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ACY1—kidney cancer	7.36e-05	0.00559	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—CYP1A1—kidney cancer	7.16e-05	0.00544	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.16e-05	0.00544	CbGpPWpGaD
Sulfadiazine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.06e-05	0.00537	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	6.34e-05	0.00481	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.19e-05	0.0047	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	6.11e-05	0.00464	CbGpPWpGaD
Sulfadiazine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.11e-05	0.00464	CbGpPWpGaD
Sulfadiazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	5.97e-05	0.00453	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	5.83e-05	0.00443	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.8e-05	0.00441	CbGpPWpGaD
Sulfadiazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	5.68e-05	0.00432	CbGpPWpGaD
Sulfadiazine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.34e-05	0.00405	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTT1—kidney cancer	5.11e-05	0.00388	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.04e-05	0.00383	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.02e-05	0.00381	CbGpPWpGaD
Sulfadiazine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.97e-05	0.00377	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—PTGS1—kidney cancer	4.78e-05	0.00363	CbGpPWpGaD
Sulfadiazine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.61e-05	0.0035	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTT1—kidney cancer	4.41e-05	0.00335	CbGpPWpGaD
Sulfadiazine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.33e-05	0.00329	CbGpPWpGaD
Sulfadiazine—CYP2C8—Arachidonic acid metabolism—PTGS2—kidney cancer	4.26e-05	0.00323	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.18e-05	0.00317	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—PTGS1—kidney cancer	4.13e-05	0.00314	CbGpPWpGaD
Sulfadiazine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.11e-05	0.00312	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.08e-05	0.0031	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.03e-05	0.00306	CbGpPWpGaD
Sulfadiazine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	3.94e-05	0.00299	CbGpPWpGaD
Sulfadiazine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.75e-05	0.00285	CbGpPWpGaD
Sulfadiazine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.74e-05	0.00284	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.65e-05	0.00277	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTT1—kidney cancer	3.59e-05	0.00273	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTP1—kidney cancer	3.54e-05	0.00269	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTP1—kidney cancer	3.49e-05	0.00265	CbGpPWpGaD
Sulfadiazine—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	3.47e-05	0.00263	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—PTGS1—kidney cancer	3.37e-05	0.00256	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.32e-05	0.00252	CbGpPWpGaD
Sulfadiazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.28e-05	0.00249	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—GSTM1—kidney cancer	3.25e-05	0.00247	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	3.21e-05	0.00244	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	3.08e-05	0.00234	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTP1—kidney cancer	3.06e-05	0.00232	CbGpPWpGaD
Sulfadiazine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.04e-05	0.00231	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	3.04e-05	0.00231	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTP1—kidney cancer	3.02e-05	0.00229	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.97e-05	0.00226	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—GSTM1—kidney cancer	2.81e-05	0.00213	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—GSTM1—kidney cancer	2.77e-05	0.00211	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ACY1—kidney cancer	2.71e-05	0.00206	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.69e-05	0.00205	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—CYP1A1—kidney cancer	2.66e-05	0.00202	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metapathway biotransformation—CYP1A1—kidney cancer	2.63e-05	0.002	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTP1—kidney cancer	2.49e-05	0.00189	CbGpPWpGaD
Sulfadiazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.48e-05	0.00188	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	2.46e-05	0.00186	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.37e-05	0.0018	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ACY1—kidney cancer	2.34e-05	0.00178	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PDHB—kidney cancer	2.31e-05	0.00175	CbGpPWpGaD
Sulfadiazine—CYP2E1—Biological oxidations—POMC—kidney cancer	2.3e-05	0.00175	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.29e-05	0.00174	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.26e-05	0.00171	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.22e-05	0.00169	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.17e-05	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CCBL1—kidney cancer	2.17e-05	0.00165	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.14e-05	0.00162	CbGpPWpGaD
Sulfadiazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.01e-05	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2e-05	0.00152	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PDHB—kidney cancer	1.99e-05	0.00151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Biological oxidations—POMC—kidney cancer	1.99e-05	0.00151	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ACY1—kidney cancer	1.91e-05	0.00145	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPAT—kidney cancer	1.88e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GLIPR1—kidney cancer	1.88e-05	0.00143	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CCBL1—kidney cancer	1.87e-05	0.00142	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APRT—kidney cancer	1.75e-05	0.00133	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—FH—kidney cancer	1.75e-05	0.00133	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.69e-05	0.00129	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GPC3—kidney cancer	1.64e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.64e-05	0.00125	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.63e-05	0.00124	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPAT—kidney cancer	1.62e-05	0.00123	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GLIPR1—kidney cancer	1.62e-05	0.00123	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PDHB—kidney cancer	1.62e-05	0.00123	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.62e-05	0.00123	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—POMC—kidney cancer	1.62e-05	0.00123	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.6e-05	0.00122	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CA2—kidney cancer	1.6e-05	0.00121	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.59e-05	0.00121	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALAD—kidney cancer	1.56e-05	0.00118	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CCBL1—kidney cancer	1.52e-05	0.00116	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ST3GAL2—kidney cancer	1.52e-05	0.00115	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—FH—kidney cancer	1.51e-05	0.00115	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APRT—kidney cancer	1.51e-05	0.00115	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.51e-05	0.00115	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.49e-05	0.00113	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDH1A1—kidney cancer	1.49e-05	0.00113	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.48e-05	0.00112	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.43e-05	0.00109	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PGK1—kidney cancer	1.42e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC5A3—kidney cancer	1.42e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GPC3—kidney cancer	1.42e-05	0.00108	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.41e-05	0.00107	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—LDHB—kidney cancer	1.4e-05	0.00106	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CA2—kidney cancer	1.38e-05	0.00105	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.38e-05	0.00105	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALAD—kidney cancer	1.35e-05	0.00102	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPAT—kidney cancer	1.32e-05	0.001	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.32e-05	0.001	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.31e-05	0.000998	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.31e-05	0.000992	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.29e-05	0.000982	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.28e-05	0.000975	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACY1—kidney cancer	1.26e-05	0.000956	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.23e-05	0.000935	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PGK1—kidney cancer	1.23e-05	0.000935	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—FH—kidney cancer	1.23e-05	0.000934	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APRT—kidney cancer	1.23e-05	0.000934	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CA9—kidney cancer	1.21e-05	0.00092	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—LDHB—kidney cancer	1.21e-05	0.000917	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.2e-05	0.000913	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GPC3—kidney cancer	1.16e-05	0.000878	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CA2—kidney cancer	1.12e-05	0.000854	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALAD—kidney cancer	1.1e-05	0.000832	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PDHB—kidney cancer	1.07e-05	0.000812	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.07e-05	0.000812	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.07e-05	0.00081	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CA9—kidney cancer	1.05e-05	0.000795	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.05e-05	0.000794	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CRABP1—kidney cancer	1.03e-05	0.000782	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.02e-05	0.000777	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.01e-05	0.000764	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC5A3—kidney cancer	1e-05	0.000761	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PGK1—kidney cancer	1e-05	0.000761	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—LDHB—kidney cancer	9.83e-06	0.000746	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ITPR2—kidney cancer	9.57e-06	0.000727	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CRABP1—kidney cancer	8.9e-06	0.000676	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ACHE—kidney cancer	8.73e-06	0.000663	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTT1—kidney cancer	8.73e-06	0.000663	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.72e-06	0.000662	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPAT—kidney cancer	8.72e-06	0.000662	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CA9—kidney cancer	8.52e-06	0.000647	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.33e-06	0.000633	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ITPR2—kidney cancer	8.28e-06	0.000629	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SCARB1—kidney cancer	8.26e-06	0.000628	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS1—kidney cancer	8.18e-06	0.000621	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—FH—kidney cancer	8.11e-06	0.000616	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APRT—kidney cancer	8.11e-06	0.000616	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PSMD7—kidney cancer	8.02e-06	0.000609	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.63e-06	0.000579	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GPC3—kidney cancer	7.62e-06	0.000579	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—BCHE—kidney cancer	7.61e-06	0.000578	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—kidney cancer	7.55e-06	0.000573	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ACHE—kidney cancer	7.55e-06	0.000573	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC5A5—kidney cancer	7.51e-06	0.000571	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CA2—kidney cancer	7.41e-06	0.000563	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SLC2A1—kidney cancer	7.26e-06	0.000551	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CRABP1—kidney cancer	7.24e-06	0.00055	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALAD—kidney cancer	7.23e-06	0.000549	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SCARB1—kidney cancer	7.14e-06	0.000543	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS1—kidney cancer	7.07e-06	0.000537	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.05e-06	0.000536	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PSMD7—kidney cancer	6.93e-06	0.000527	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.89e-06	0.000524	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ITPR2—kidney cancer	6.73e-06	0.000512	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.61e-06	0.000502	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PGK1—kidney cancer	6.61e-06	0.000502	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—BCHE—kidney cancer	6.57e-06	0.000499	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC5A5—kidney cancer	6.49e-06	0.000493	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—LDHB—kidney cancer	6.48e-06	0.000492	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SLC2A1—kidney cancer	6.27e-06	0.000476	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.21e-06	0.000472	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—kidney cancer	6.14e-06	0.000467	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ACHE—kidney cancer	6.14e-06	0.000467	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.08e-06	0.000462	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—kidney cancer	6.05e-06	0.00046	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SCARB1—kidney cancer	5.81e-06	0.000442	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS1—kidney cancer	5.76e-06	0.000437	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCB1—kidney cancer	5.73e-06	0.000435	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PSMD7—kidney cancer	5.64e-06	0.000429	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CA9—kidney cancer	5.62e-06	0.000427	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—kidney cancer	5.56e-06	0.000422	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—BCHE—kidney cancer	5.35e-06	0.000406	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.31e-06	0.000403	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.28e-06	0.000401	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—kidney cancer	5.27e-06	0.0004	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—kidney cancer	5.23e-06	0.000397	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.1e-06	0.000388	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.95e-06	0.000376	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCB1—kidney cancer	4.95e-06	0.000376	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—kidney cancer	4.81e-06	0.000365	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CRABP1—kidney cancer	4.78e-06	0.000363	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.56e-06	0.000346	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ITPR2—kidney cancer	4.44e-06	0.000337	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.32e-06	0.000328	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—kidney cancer	4.26e-06	0.000323	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—kidney cancer	4.05e-06	0.000308	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ACHE—kidney cancer	4.05e-06	0.000308	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCB1—kidney cancer	4.03e-06	0.000306	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—POMC—kidney cancer	3.93e-06	0.000299	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—kidney cancer	3.91e-06	0.000297	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.83e-06	0.000291	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.8e-06	0.000288	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.74e-06	0.000284	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.72e-06	0.000283	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.71e-06	0.000282	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—BCHE—kidney cancer	3.53e-06	0.000268	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.49e-06	0.000265	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—POMC—kidney cancer	3.4e-06	0.000258	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.37e-06	0.000256	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—kidney cancer	3.14e-06	0.000238	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.05e-06	0.000231	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.81e-06	0.000213	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—POMC—kidney cancer	2.77e-06	0.00021	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTEN—kidney cancer	2.73e-06	0.000208	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—kidney cancer	2.71e-06	0.000206	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.66e-06	0.000202	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.58e-06	0.000196	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.45e-06	0.000186	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTEN—kidney cancer	2.36e-06	0.00018	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—kidney cancer	2.21e-06	0.000168	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.93e-06	0.000147	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTEN—kidney cancer	1.92e-06	0.000146	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—POMC—kidney cancer	1.82e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.67e-06	0.000127	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.45e-06	0.00011	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.36e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTEN—kidney cancer	1.27e-06	9.63e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.95e-07	6.8e-05	CbGpPWpGaD
